These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7979663)

  • 41. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical treatment of a case of arrhythmogenic right ventricular dysplasia with local myocardial resections].
    Katsumoto K; Niibori T
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Sep; 37(9):1984-8. PubMed ID: 2600475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical application of an integrated 3-phase mapping technique for localization of the site of origin of idiopathic ventricular tachycardia.
    Peeters HA; SippensGroenewegen A; Wever EF; Ramanna H; Linnenbank AC; Potse M; Grimbergen CA; van Hemel NM; Hauer RN; Robles de Medina EO
    Circulation; 1999 Mar; 99(10):1300-11. PubMed ID: 10077513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia.
    Lin D; Hsia HH; Gerstenfeld EP; Dixit S; Callans DJ; Nayak H; Russo A; Marchlinski FE
    Heart Rhythm; 2005 Sep; 2(9):934-9. PubMed ID: 16171747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?
    Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH
    Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
    Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy.
    Havranek S; Palecek T; Kovarnik T; Vitkova I; Psenicka M; Linhart A; Wichterle D
    BMC Cardiovasc Disord; 2015 Mar; 15():18. PubMed ID: 25887693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age related dilatation of the right ventricle in arrhythmogenic right ventricular dysplasia-cardiomyopathy.
    Peters S
    Int J Cardiol; 1996 Oct; 56(2):163-7. PubMed ID: 8894788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy.
    Fernández-Armenta J; Andreu D; Penela D; Trucco E; Cipolletta L; Arbelo E; Berne P; María Tolosana J; Pedrote A; Brugada J; Mont L; Berruezo A
    Heart Rhythm; 2014 May; 11(5):747-54. PubMed ID: 24561159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of body surface maps to demonstrate ventricular activation patterns during left ventricular pacing and reentrant activation during ventricular tachycardia in men with coronary heart disease and left ventricular dysfunction.
    McClelland AJ; Owens CG; Navarro C; Smith B; Roberts MJ; Anderson J; Adgey AA
    Am J Cardiol; 2006 Sep; 98(5):591-6. PubMed ID: 16923442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgery for ventricular tachycardia of left ventricular origin: risk factors for success and long-term outcome.
    von Oppell UO; Milne D; Okreglicki A; Scott Millar RN
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):762-70. PubMed ID: 12414043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Radiofrequency catheter ablation of ventricular tachycardia in patients without apparent structural cardiopathy].
    Peinado Peinado R; Arenal Maíz A; Almendral Garrote J; Pérez Villacastín J; Merino Llorens JL; Martínez-Alday JD; Pastor Fuentes A; Medina Moreno O; Valero Parra R; Delcán Domínguez JL
    Rev Esp Cardiol; 1994 Dec; 47(12):803-10. PubMed ID: 7855375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histologic findings of long-term cryolesions in a patient with ventricular tachycardia.
    Watanabe H; Eguchi S; Miyamura H; Hayashi J; Aizawa Y; Wakiya Y; Igarashi T
    Cardiovasc Surg; 1996 Jun; 4(3):409-11. PubMed ID: 8782949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
    Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
    Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers.
    Hayashi M; Kobayashi Y; Iwasaki YK; Morita N; Miyauchi Y; Kato T; Takano T
    Heart Rhythm; 2006 Aug; 3(8):908-18. PubMed ID: 16876739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.
    Yao Y; Zhang S; He DS; Zhang K; Hua W; Chu J; Pu J; Chen K; Wang F; Chen X
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):526-33. PubMed ID: 17437577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.